PYPD

6.1206.56%
DH

Dalit Hazan

Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs

Ms. Dalit Hazan serves as Executive Vice President of R&D and Clinical & Regulatory Affairs at PolyPid Ltd. since March 2022 and is its Deputy Chief Executive Officer since August 2024. She had been Senior Vice President, Research and Development and Regulatory Affairs since June 2021 and had served as Vice President of Research and Development and Regulatory Affairs since March 2018 at PolyPid Ltd. Ms. Hazan was the head of Global Regulatory Affairs at Teva Pharmaceuticals Industries Ltd. From 2013 to April 2016. She holds a B.S. in biology and a M.S. in physiology and pharmacology from the Sackler Faculty of Medicine at Tel Aviv University and an Executive MBA from Bar Ilan University.

Positions